A 45-year-old man, known to be hypertensive and with a history of smoking (5 cigarettes a day for 18 years), presented to Tygerberg Hospital with peripheral vascular disease necessitating bilateral amputations at the knee. The patient had no other significant medical disorders and no previous history of tuberculosis (TB), and consumed alcohol socially. He had been well before this admission, with no previous medical or surgical admissions. The findings on general and systemic examination were normal and no lumps were noted on the body.The patient was tested for HIV as part of his surgical work-up and was found to be positive with a CD4 count of 152 cells/µl. He was commenced on ARVs: stavudine (D4T) 30 mg 12-hourly, lamivudine (3TC) 150 mg 12-hourly and efavirenz (EFV) 600 mg at night. He underwent successful above-knee amputations and was subsequently followed up at the Tygerberg Hospital Infectious Disease Clinic approximately 1 month later.The patient was doing well and reported no problems or side-effects from the ARVs. The stumps were clean and findings on a thorough physical examination were normal. No lumps were detected on the patient's body at this visit. The patient had no symptoms of TB, but a chest radiograph revealed infiltrates in the right upper zone. At this stage we were still awaiting sputum results from his initial admission. Two weeks later (approximately 6 weeks after ARV initiation) drugsusceptible TB was diagnosed on sputum culture. TB treatment was immediately commenced.The patient returned for a follow-up visit after a further 2 weeks complaining of multiple lumps on the trunk and abdomen. Physical examination revealed multiple soft, mobile, non-tender nodules on the abdomen (Fig. 1), measuring approximately 2×2 cm. A fine-needle aspirate and excision biopsy confirmed that these were lipomas. A fasting lipogram revealed a total cholesterol level of 5.7 mmol/l, a triglyceride level of 2.0 mmol/l, a high-density lipoprotein (HDL) cholesterol level of 1.2 mmol/l and a low-density lipoprotein (LDL) cholesterol level of 3.6 mmol/l.The patient was counselled regarding his condition and continued on his anti-TB treatment and ARVs. He was started on the appropriate medical management for his dyslipidaemia and given appropriate dietary advice.
A RARE PHENOMENON OF ATYPICAL LIPODYSTROPHY IN A PATIENT ON HAART IN THE ABSENCE OF A PROTEASE INHIBITOR REGIMEN
C A S E S T U DY
37Lipodystrophy is a complication of patients on antiretroviral (ARV) medication; however, it is commonest in patients on long-term treatment and those on protease inhibitor (PI) regimens. 1,2 We present a rare case of atypical lipodystrophy, presenting as multiple subcutaneous lipomas, in a patient who had been on a non-PI ARV regimen for 6 weeks.